The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes

The efficacy and safety of once‐weekly dulaglutide 0.75 mg (dulaglutide) in Japanese patients with type 2 diabetes (T2D) were evaluated according to subgroups defined by concomitant oral hypoglycaemic agents. This exploratory analysis included data from a randomized, open‐label, phase III study that...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Obes Metab
Huvudupphovsmän: Inagaki, Nobuya, Araki, Eiichi, Oura, Tomonori, Matsui, Akiko, Takeuchi, Masakazu, Tanizawa, Yukio
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2016
Ämnen:
Brief Reports
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5129571/
https://ncbi.nlm.nih.gov/pubmed/27488246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12758
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk